Literature DB >> 2047653

Digalactosyl-containing glycolipids as cell surface receptors for shiga toxin of Shigella dysenteriae 1 and related cytotoxins of Escherichia coli.

J E Brown1, P Echeverria, A A Lindberg.   

Abstract

Purified glycolipids containing galactose-alpha(1-4)galactose bind with Shiga toxin of Shigella dysenteriae 1 and Shiga-like toxins of Escherichia coli with high specificity in both thin-layer chromatograms and glycolipid-coated microtiter plates. These glycolipids appear to be the natural cell surface receptors for this class of bacterial toxins since artificial glycoconjugates block cytotoxicity as well as binding of 125I-labeled toxin. Cell lines lacking these glycolipids are refractory to toxin action. Assays in which synthetic glycoconjugates and purified glycolipids are used as capture reagents have been developed for the detection of the toxins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2047653     DOI: 10.1093/clinids/13.supplement_4.s298

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  7 in total

Review 1.  Blood Groups in Infection and Host Susceptibility.

Authors:  Laura Cooling
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

2.  Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid.

Authors:  L L Cooling; K E Walker; T Gille; T A Koerner
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

3.  Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro.

Authors:  S A Kaye; C B Louise; B Boyd; C A Lingwood; T G Obrig
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

4.  Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages.

Authors:  V L Tesh; B Ramegowda; J E Samuel
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

5.  Binding of Pk-trisaccharide analogs of globotriaosylceramide to Shiga toxin variants.

Authors:  Hailemichael O Yosief; Suri S Iyer; Alison A Weiss
Journal:  Infect Immun       Date:  2013-05-20       Impact factor: 3.441

Review 6.  Future perspectives for glycolipid research in medicine.

Authors:  Timothy M Cox
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-05-29       Impact factor: 6.237

Review 7.  Molecular Biology of Escherichia Coli Shiga Toxins' Effects on Mammalian Cells.

Authors:  Christian Menge
Journal:  Toxins (Basel)       Date:  2020-05-23       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.